Amgen Inc. AMGN
Set alert
465.25 USD -0.20 -0.04%
As of Nov 3, 11:24 AM ET
461.40 Day range 467.02
296.30 52-week range 466.01
- YTD
- +42.14%
- 1 year
- +57.02%
- Open
- 462.45
- Prev close
- 465.45
- Mkt cap
- 251.52B
- Vol
- 442.11K
- Avg vol
- 2.80M
- EPS
- 16.10
- P/E
- 28.90
- Div yield
- 2.19%
More statistics
- Low
- 461.40
- High
- 467.02
- Forward P/E
- 19.01
- Beta
- 0.42
- Short ratio
- 4.35
- Inst. own
- 85.13%
- Dividend
- 10.08
- Ex-div date
- Nov 19, 2026
- Earnings
- Nov 3, 2026
- 50-d avg
- 419.96
- 200-d avg
- 374.79
- 1y target
- 397.32
3M chart
Events in this range
- Aug 4, 2026Earnings: 6.29; estimate 5.62; surprise 11.92%
- Aug 21, 2026Dividend: 2.52
- Oct 9, 2026Rating: UBS · Buy → Buy
- Oct 12, 2026Rating: Wells Fargo · Equal-Weight → Equal-Weight
- Oct 12, 2026Rating: BMO Capital · Market Perform → Market Perform
- Oct 13, 2026Rating: Guggenheim · Neutral → Neutral
- Oct 21, 2026Rating: Barclays · Equal-Weight → Equal-Weight
- Oct 23, 2026Rating: Oppenheimer · Outperform → Outperform
- Nov 3, 2026Earnings: —; estimate 5.79; surprise —%
Signals (19)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 30, 2026 | 4 days ago |
| SMA: Bullish | Oct 14, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 13, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 8, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 8, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 7, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 7, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| SMA: Bullish | Sep 25, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 24, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| RSI: Overbought | Aug 7, 2026 | 2 months ago |
| RSI: Overbought | Aug 5, 2026 | 3 months ago |
Analyst view
Consensus: hold
Hold
Price target (mean) 397.32 -14.6% downside
Now 465.25
- Target (low)
- 225.00
- Target (mean)
- 397.32
- Target (high)
- 500.00
Ratings (0m) 34 12 buy · 17 hold · 5 sell
- Strong buy4
- Buy8
- Hold17
- Sell3
- Strong sell2
Recommendation trend
- This month 34
- 1 month ago 34
- 2 months ago 34
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 5.78 | 5.47 – 6.09 | 5.64 | +2.5% | 10.07B | +5.3% | 29 |
| Next quarter | 5.77 | 5.19 – 6.10 | 5.29 | +9.1% | 10.27B | +4.1% | 26 |
| Current year | 23.02 | 22.49 – 23.44 | 21.84 | +5.4% | 38.97B | +6.1% | 32 |
| Next year | 24.50 | 22.88 – 26.37 | 23.02 | +6.4% | 40.40B | +3.6% | 31 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 23, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Oct 21, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 13, 2026 | Guggenheim | Maintained | Neutral | Neutral |
| Oct 12, 2026 | BMO Capital | Maintained | Market Perform | Market Perform |
| Oct 12, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 9, 2026 | UBS | Maintained | Buy | Buy |
| Oct 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 8, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Oct 7, 2026 | Truist Securities | Maintained | Hold | Hold |
| Oct 7, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Sep 29, 2026 | Scotiabank | Maintained | Sector Outperform | Sector Outperform |
| Sep 10, 2026 | HSBC | Downgrade | Buy | Hold |
| Sep 8, 2026 | BMO Capital | Downgrade | Outperform | Market Perform |
| Sep 8, 2026 | Cantor Fitzgerald | Reiterated | Neutral | Neutral |
| Sep 4, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Aug 20, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 19, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Aug 19, 2026 | Argus Research | Maintained | Buy | Buy |
| Aug 18, 2026 | Mizuho | Maintained | Neutral | Neutral |
| Aug 18, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Aug 14, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Aug 10, 2026 | Guggenheim | Maintained | Neutral | Neutral |
| Aug 7, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Aug 6, 2026 | Bernstein | Maintained | Market Perform | Market Perform |
| Aug 5, 2026 | Baird | Maintained | Underperform | Underperform |
| Aug 5, 2026 | Canaccord Genuity | Maintained | Hold | Hold |
| Aug 5, 2026 | B of A Securities | Maintained | Underperform | Underperform |
| Aug 5, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Aug 5, 2026 | UBS | Maintained | Buy | Buy |
| Aug 5, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |